Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
about
Intramyocellular lipid kinetics and insulin resistanceMitochondria in the diabetic heartThe non-coding RNA gadd7 is a regulator of lipid-induced oxidative and endoplasmic reticulum stressCardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium ChannelsNew Molecular Insights of Insulin in Diabetic CardiomyopathyReactive oxygen species, nutrition, hypoxia and diseases: Problems solved?Lean heart: Role of leptin in cardiac hypertrophy and metabolismMitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyAlterations in mouse hypothalamic adipokine gene expression and leptin signaling following chronic spinal cord injury and with advanced ageCardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterificationCell Death and Heart Failure in Obesity: Role of Uncoupling ProteinsDiabetic Cardiomyopathy: Does the Type of Diabetes Matter?The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureMitochondrial morphology in metabolic diseasesIn obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidationMitochondrial dysfunction in diabetic cardiomyopathyProtective mechanisms of mitochondria and heart function in diabetesMitochondrial dynamics in diabetic cardiomyopathyInsulin Signaling and Heart Failure.Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.Lipotoxicity in the heart.GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.Obesity and preclinical changes of cardiac geometry and function.Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenationDeficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinMetabolic and Biochemical Stressors in Diabetic Cardiomyopathy.Maintaining PGC-1α expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function.High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injuryInsulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts.Diabetic cardiomyopathy, causes and effects.Cardiac remodeling in obesity.PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.Obesity and atrial fibrillation.Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overloadCaptopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts.Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity.Proteomic changes in the heart of diet-induced pre-diabetic mice.
P2860
Q21245684-60130C18-0850-47D0-8317-DAAF2B3BE74CQ24633336-5CE634AE-A41F-486F-9266-1F297B313306Q24655508-253EC8A4-52FD-4F18-9EC8-7FAF16CC965EQ26751133-20EF2AAD-BE44-4BD4-92F0-2E28BFC2D882Q26752678-581505EB-443D-4EA5-ACF8-EA387E2F23B3Q26784413-1D7DBC76-70C2-4DFB-AA1B-FC617AB28F32Q26785951-FA484017-290B-4445-B209-06138A3EE5D4Q26859582-B35F906D-05EC-439E-9658-F06C65A879AEQ27333098-D3E5CD74-5442-46A4-A883-E7C07213326DQ27887261-01F5765B-9B51-466B-BD82-4022C43B6319Q28072387-2DCB7DF7-C717-4108-9407-2B253118195FQ28079593-11785488-FA75-442E-8D0D-C7C31E78231DQ28082343-910F01B4-2759-456A-B833-1320C1111828Q28385060-DEFA8086-971A-4350-BFA4-B92F34221695Q28386200-BDEE5E7A-ADF2-4490-A739-6D083C53F2B5Q28390863-6364E395-C4D7-4C93-894B-F2D22B82EDFFQ28395215-6ECF73C3-3354-4795-B2E1-09C82532A109Q28395223-DA58B55E-6E64-4BD0-8AE9-56A9466EEC44Q30377910-4910A4D1-E60B-449F-9DF0-C65954A8E2ADQ33434386-073EAD6D-28C5-4FA4-A294-AC85A8E719F9Q33568098-E4E9A135-1261-407B-9192-AE59746A0A55Q33665107-71B04781-D40C-429C-9EEC-C5A15283C7BEQ33680469-A3166A18-2D61-4401-BB75-1B09F848E93FQ33685011-5EF4F4F2-F954-406F-B025-6D4EEE5EFEA5Q33705758-5E1ED523-FEAA-4978-A423-4B755EBD5226Q33719493-1A977DB8-0325-492F-8B0D-F52579D25FB9Q33740554-E683AF68-1456-4685-918A-308BC226BFD3Q33913178-CF0E11C7-BB2A-416E-A9F4-AEC4D98F5BF1Q33948647-96B197D3-F6EC-4A6D-A9CF-BCBAC13F43F3Q33959744-CE5947D5-E4C7-4E74-838A-D72AA9EE7394Q34038623-EA3FAF10-0955-4EB8-9317-8F9E1AF60D97Q34043589-876263B8-F99E-47DD-B71A-EA10B6990567Q34162103-4CB96E8F-484B-4FEB-9C94-832E6A651A04Q34305220-0FBD4BBD-5CBB-4642-9FA9-68EE0A06FFB8Q34359362-36D4C92D-123C-4160-965A-8DE8D6442101Q34410318-1E96AF9B-81CB-4B64-91D8-FC65A3FFDB89Q34502029-4DEDDBD3-F458-4AD2-B73C-B25F955B0EB6Q34591369-890386BE-8BF3-4545-BADB-4369B9A7E01FQ34789756-878076EA-9C17-4439-ADFE-4B2E6A60F92DQ34847102-66D493C7-30F6-4D34-A6C6-E6F2059D55EF
P2860
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@en
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@nl
type
label
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@en
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@nl
prefLabel
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@en
Impaired cardiac efficiency an ...... -resistant ob/ob mouse hearts.
@nl
P2093
P1433
P1476
Impaired cardiac efficiency an ...... n-resistant ob/ob mouse hearts
@en
P2093
Jonathan Buchanan
Matthew W Roberts
Pradip K Mazumder
Robert C Cooksey
Sihem Boudina
Ui Jeong Yun
P304
P356
10.2337/DIABETES.53.9.2366
P407
P577
2004-09-01T00:00:00Z